Company / Shareholders' Equity
LIFECORE BIOMEDICAL, INC. \DE\ Shareholders' Equity History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$252.6M
FY2019
5-year range
$210.7M / $252.6M
FY2015-FY2019
Trend
+0.0%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $211M to $253M over the past 2 years.
Based on SEC 10-K filings.
$253M in FY2019 with a 5-year CAGR of +4.5%.
Improved from $211M to $253M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +4.5%, indicating consistent growth.
- In FY2019, shareholders' equity increased 0.0% year-over-year.
- Lowest shareholders' equity in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $252.6M | +0.0% |
| FY2018 | $252.6M | +19.9% |
| FY2017 | $210.7M | +0.0% |
| FY2016 | $210.7M | -3.5% |
| FY2015 | $218.4M | +7.6% |
| FY2014 | $203.1M | +13.6% |
| FY2013 | $178.7M | +19.3% |
| FY2012 | $149.7M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026